Showing results (1381-1390 of 2,286) with videos related to

Sort By:
Pageof 229
HIV Medicine|November 16, 2019
Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populationsR M Brusca, D B Hanna, N I Wada, et al.
HIV Medicine|November 16, 2019
Post-exposure prophylaxis following consented sexual exposure: impact of national recommendations on user profile, drug regimens and estimates of averted HIV infectionsI O Pereira, Arp Pascom, G Mosimann, et al.
HIV Medicine|July 21, 2021
Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trialB Torres, A C Guardo, M Squarcia, et al.
HIV Medicine|July 22, 2021
Longitudinal analysis of client appointment adherence under Universal Test and Treat strategy: A stepped-wedge trialCaroline E Boeke, Shaukat Khan, Fiona J Walsh, et al.
HIV Medicine|May 6, 2022
Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical surveyMichaela Tinggaard, Kim Peter David, Jan Gerstoft, et al.
HIV Medicine|July 30, 2021
In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrelOwain Roberts, Hannah Kinvig, Andrew Owen, et al.
HIV Medicine|July 28, 2021
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohortMassimiliano Fabbiani, Barbara Rossetti, Arturo Ciccullo, et al.
HIV Medicine|April 19, 2013
Limitations to the identification of HIV-associated neurocognitive disorders in clinical practiceD Morley, P McNamara, S Kennelly, et al.
HIV Medicine|May 15, 2013
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analoguesM M Santoro, C Sabin, F Forbici, et al.
HIV Medicine|April 5, 2013
Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherenceA Nelsen, S Gupta, B W Trautner, et al.
Pageof 229